Previous Article | Next Article ![]()
Journal of Virology, December 2001, p. 11974-11982, Vol. 75, No. 24
Molecular and Cell Biology
Program,1 Center for Agricultural
Biotechnology of University of Maryland Biotechnology
Institute,2 and Virginia-Maryland
Regional College of Veterinary Medicine,3
University of Maryland, College Park, Maryland 20742
Received 4 April 2001/Accepted 20 August 2001
Infectious bursal disease viruses (IBDVs), belonging to the family
Birnaviridae, exhibit a wide range of immunosuppressive potential, pathogenicity, and virulence for chickens. The genomic segment A encodes all the structural (VP2, VP4, and VP3) and
nonstructural proteins, whereas segment B encodes the viral
RNA-dependent RNA polymerase (VP1). To identify the molecular
determinants for the virulence, pathogenic phenotype, and cell tropism
of IBDV, we prepared full-length cDNA clones of a virulent strain,
Irwin Moulthrop (IM), and constructed several chimeric cDNA clones of
segments A and B between the attenuated vaccine strain (D78) and the
virulent IM or GLS variant strain. Using the cRNA-based
reverse-genetics system developed for IBDV, we generated five chimeric
viruses after transfection by electroporation procedures in Vero or
chicken embryo fibroblast (CEF) cells, one of which was recovered after propagation in embryonated eggs. To evaluate the characteristics of the
recovered viruses in vivo, we inoculated 3-week-old chickens with D78,
IM, GLS, or chimeric viruses and analyzed their bursae for pathological
lesions 3 days postinfection. Viruses in which VP4, VP4-VP3, and VP1
coding sequences of the virulent strain IM were substituted for the
corresponding region in the vaccine strain failed to induce hemorrhagic
lesions in the bursa. In contrast, viruses in which the VP2 coding
region of the vaccine strain was replaced with the variant GLS or
virulent IM strain caused rapid bursal atrophy or hemorrhagic lesions
in the bursa, as seen with the variant or classical virulent strain,
respectively. These results show that the virulence and
pathogenic-phenotype markers of IBDV reside in VP2. Moreover, one of
the chimeric viruses containing VP2 sequences of the virulent strain
could not be recovered in Vero or CEF cells but was recovered in
embryonated eggs, suggesting that VP2 contains the determinants for
cell tropism. Similarly, one of the chimeric viruses containing the VP1
segment of the virulent strain could not be recovered in Vero cells but
was recovered in CEF cells, suggesting that VP1 contains the
determinants for cell-specific replication in Vero cells. By comparing
the deduced amino acid sequences of the D78 and IM strains and their
reactivities with monoclonal antibody 21, which binds specifically to
virulent IBDV, the putative amino acids involved in virulence and cell tropism were identified. Our results indicate that residues Gln at
position 253 (Gln253), Asp279, and Ala284 of VP2 are involved in the
virulence, cell tropism, and pathogenic phenotype of virulent IBDV.
Infectious bursal disease
virus (IBDV) belongs to the genus Avibirnavirus and is
a member of the family Birnaviridae (1, 9, 10).
The genome of IBDV consists of two segments of double-stranded RNA,
which are packaged in a nonenveloped icosahedral shell 60 nm in
diameter. The larger segment, A, is 3,261 nucleotides long, and it
encodes a 110-kDa precursor protein in a single large open reading
frame (ORF), which is cleaved by autoproteolysis to yield mature VP2,
VP3, and VP4 proteins (1, 12). VP2 and VP3 are the major
structural proteins of the virion, whereas VP4 is a minor protein
involved in the processing of the precursor protein (3, 12, 13,
28). VP2 is the major host-protective immunogen of IBDV and
contains the determinants responsible for causing antigenic variation
(6, 11, 40). VP3 is a group-specific antigen and forms a
complex with VP1, which may have an essential role for the
morphogenesis of IBDV particles (5, 19). Segment A also
encodes a 17-kDa nonstructural (NS) protein from a small ORF which
precedes and partly overlaps the large ORF (35). This NS
protein is detected only in IBDV-infected cells, and it is not required
for viral replication but plays an important role in pathogenesis
(24, 43). The smaller segment, B, is 2,827 nucleotides
long, and it encodes VP1, a 97-kDa protein having RNA-dependent RNA
polymerase activity (36). This protein is covalently
linked to the 5' ends of the genomic RNA segments (34).
IBDV infects the precursors of antibody-producing B cells in the bursa
of Fabricius (BF), which can cause severe immunosuppression and
mortality in young chickens (2, 15). Viruses of serotype I
are pathogenic to chickens, whereas serotype II viruses are avirulent
for chickens (21). IBDV isolates of serotype I display a
wide range of immunosuppressive potential, pathogenicity, and virulence
for chickens. Classic IBDV strains isolated from the United States in
the early 1960s, such as the Edgar, 2512, and Irwin Moulthrop (IM)
strains, induce hemorrhagic lesions accompanied by near-total B-cell
follicle depletion and cause between 30 and 60% mortality in
light-breed chickens. In the late 1980s, Delaware and GLS variant
viruses, which cause rapid atrophy of the bursa without the
accompanying inflammation, hemorrhage, or mortality caused by the
earlier classical strains, were isolated from the Delmarva Peninsula
(32, 33). In the mid 1990s, "very virulent" strains of
IBDV which cause >70% mortality in chickens emerged in several
European and Asian countries (6, 18, 37). To distinguish
the very virulent strains from the classic vaccine strains, a
monoclonal antibody (MAb) was generated against the virulent IM strain
(22). This MAb 21 recognizes all the very virulent IBDV
strains tested to date, but it does not react if these viruses are
adapted in tissue culture (22, 41).
Earlier studies have shown that very virulent strains of IBDV lose
their virulence potential after serial passage in non-B lymphoid
chicken cells (42). Comparison of the deduced amino acid
sequences of the very virulent (OKYM) and attenuated (OKYMT) strains
showed specific amino acid substitutions within the hypervariable region of the VP2 protein. However, due to the lack of a
reverse-genetics system that can generate virulent IBDV, it was
difficult to pinpoint the amino acids involved in virulence and cell
tropism. By carrying out site-directed mutagenesis of residues 279 and
284 in VP2, Lim and coworkers demonstrated that very virulent IBDV
could be adapted to chicken embryo fibroblast (CEF) cell culture
(17). Similarly, Mundt reported that residues 253 and 284 of the VP2 protein of the variant virus are necessary for tissue
culture infectivity (23). However, none of these viruses
were tested in chickens to verify the role of these residues in IBDV
virulence and pathogenicity. In a recent study, Boot and coworkers
rescued a very virulent IBDV, using a fowlpox-based reverse-genetics
system, and demonstrated that VP2 is not the sole determinant of the
very virulent phenotype (4). However, except for VP2, the
possible role of viral proteins in virulence, cell tropism, and the
pathogenic phenotype has not yet been determined.
Therefore, in order to identify the viral protein(s) of IBDV that is
involved in virulence, cell tropism, and the pathogenic phenotype, we
constructed chimeric clones between the attenuated vaccine strain D78
and either the virulent (IM) or the variant (GLS) strain by exchanging
VP2-, VP4-, VP4 and -3, or VP1-encoding cDNA fragments. Using the
cRNA-based reverse-genetics system for IBDV, we recovered five chimeric
viruses, including the virulent one, which contains the epitope
recognized by MAb 21 (virulence marker). In this report, we describe
the characteristics of these recovered viruses in vitro and in vivo and
identify the protein(s) and putative amino acid residues involved in
virulence, cell tropism, and the pathogenic phenotype.
Cells, viruses, and hybridomas.
Vero cells were maintained
in M199 medium supplemented with 5% fetal bovine serum (FBS) at 37°C
in a humidified 5% CO2 incubator and were used for
propagation of the virus and transfection experiments. Primary CEF
cells were prepared from 10-day-old embryonated eggs (SPAFAS, Inc.,
Storrs, Conn.) as described previously (25). Secondary CEF
cells were maintained in a growth medium consisting of M199-F10
(50%-50% [vol/vol]) and 5% FBS and were used for transfection, virus titration, immunofluorescence, and plaque assays. Virus stocks
were established by serial passage of the recombinant viruses in the
cell cultures, except one (recombinant IMVP2 [rIMVP2]), which was
propagated in embryonated eggs. The D78 vaccine strain and the
recovered chimeric viruses were titrated in secondary CEF cells as
described previously (25), whereas rIMVP2 was titrated in
eggs. The virulent IM and GLS strains of IBDV were obtained from bursae
of infected specific-pathogen-free chickens and purified as described
previously (25). A panel of MAbs, prepared against various
strains of IBDV, was used to characterize IBDV antigens by antigen
capture-enzyme-linked immunosorbent assay (AC-ELISA), as described
previously (33, 39). All classical strains of IBDV reacted
with MAbs B69, R63, and B29, whereas MAb 57 recognized only the GLS
variant strain. In addition, MAb 21 prepared against the IM strain was
used, which reacted only with the highly virulent IBDV strains
(22).
Construction of full-length cDNA clones.
All manipulations
of DNAs were performed according to standard protocols
(27). Construction of a full-length cDNA clone of IBDV
genome segment A of strain D78 (with sequence tags), pUC19FLAD78mut, has been described previously (25). It encodes all of the
structural proteins (VP2, VP4, and VP3), as well as the NS protein
(Fig. 1). The cloning of segment A of
IBDV strain IM was achieved by generating four overlapping cDNA clones.
First, the VP2 region of IBDV segment A was cloned by reverse
transcription (RT)-PCR, using the oligonucleotide primers
IBDVP2R (5'-CCAATTGCATGGGCTAGG-3'; binding to nucleotide
positions 1534 to 1551) and BamBV (5'-ACGATCGCAGCGATGACAAACCTG-3'; binding to nucleotide positions 119 to 141). This fragment was cloned into a pCR2.1 vector (Invitrogen) to produce pCRIMVP2. The 5'
end of IBDV segment A was cloned by RT-PCR, using the oligonucleotide primers 5'IR (5'-CACAGTCAAAATGTAGGTCGA-3'; binding to
nucleotide positions 256 to 277) and A5'D78 (25).
Similarly, the 3' end of IBDV segment A was cloned by RT-PCR, using the
oligonucleotide primers A3'D78 (25) and 3'IF
(5'-CAGATGAAAGATCTGCTTG-3'; binding to nucleotide positions
3011 to 3031). Both of these fragments were cloned into pCR2.1 to
obtain the plasmids pCRIM5' and pCRIM3', which were used for sequence
analysis. The remaining portion of IM segment A, which encodes VP4 and
VP3, was cloned by RT-PCR, using primers IBDVP2F
(5'-GCTTCAAAGACATAATCCGG-3'; binding to nucleotide positions
1458 to 1477) and BglR (5'-CAAGAGCAGATCTTTCATCTG-3'; binding
to nucleotide positions 3011 to 3031). The resulting fragment was then
cloned in pCR2.1 to obtain pCRIMVP43. Plasmids pUC19IMVP2 and
pUC19GLSVP2 were prepared by replacing an MfeI fragment in plasmid pUC19FLAD78mut with the respective MfeI fragments
derived from plasmids pCRIMVP2 and pGLS-5, as shown in Fig. 1. The
cloning of genomic segment A of IBDV strain GLS and the construction of plasmid pGLS-5 have been described previously (39).
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.24.11974-11982.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Molecular Determinants of Virulence, Cell Tropism,
and Pathogenic Phenotype of Infectious Bursal Disease Virus

![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

View larger version (32K):
[in a new window]
FIG. 1.
Schematic presentation of various cDNA constructs of IM,
D78, and GLS strains in order to generate plus-sense RNA transcripts
using T7 RNA polymerase. A map of the IBDV genome segments A and B,
with its coding capacity, is shown at the top (drawn to scale). The
open boxes depict the coding regions of the D78 strain, whereas the
solid and shaded boxes represent the coding regions of the IM and GLS
strains, respectively. Selected restriction sites, important for the
construction of chimeric cDNA clones of segment A, are shown. B,
BglII; M, MfeI, N, NdeI; S,
SpeI; X, XhoI. The use of restriction enzymes to
generate these chimeric clones did not alter the reading frame of the
polyprotein and hence did not cause extensions or deletions of the VP2
(residues 1 to 512), VP4 (residues 513 to 754), or VP3 (residues 755 to
1012) proteins. All of the constructs contain a T7 polymerase promoter
sequence at the 5' end.
. Next, a full-length D78 clone was constructed using this
modified pUC19
vector. The 3' end of the full-length D78 clone was
modified by PCR to produce a plasmid, pUC19
D78F, that contained a
KpnI site at the end instead of an EcoRI site.
This plasmid was used as a backbone to construct the additional clones
described below.
A full-length clone of IM segment A was constructed in several steps.
First, plasmid pUC19IMVP2 was digested with SpeI and BglII to release a 1,530-bp fragment that was further
digested with MfeI. This SpeI-MfeI
fragment was then combined with the MfeI-BglII
fragment of pCRIMVP43 and cloned back into the pUC19IMVP2 vector to
obtain pUC19IMVP243. An RsrII-BglII fragment from
this plasmid was obtained by digestion with the RsrII and
BglII enzymes. This fragment was then combined with the
BglII-BsrGI fragment of plasmid pCRIM3'NC and
ligated into the RsrII-BsrGI-digested pUC19
D78F vector. This created a full-length clone, pUC19
IMA, which contains all of the coding sequence of IM segment A but lacks the
two nucleotide changes in the 5' noncoding region of wild-type IM. This
construct is not shown in Fig. 1. To evaluate the role of VP4 in
virulence, plasmid pUC19
D78F was digested with the XhoI
enzyme to release the VP4 coding fragment, which was then replaced with
the XhoI fragment, derived from pCRIMVP43 (without altering
the reading frame), to create plasmid pUC19
IMVP4. In this chimera,
residues at positions 517, 588, and 702 of D78 were replaced with
residues of the IM strain (Table 1).
Similarly, to prove that the determinants of virulence, cell tropism,
and pathogenicity do not reside in VP4 and VP3, we constructed clone pUC19
IMVP43 by digesting plasmid pUC19
IMA with MfeI
and replacing this fragment with the MfeI portion of
pUC19
D78F (Fig. 1). As a result of this chimera, two additional
residues at positions 923 and 981 of the D78 VP3 protein were replaced
with residues of the IM strain (Table 1).
|
Transcription and transfection of synthetic RNAs.
To
generate synthetic transcripts of segments A and B, plasmids of
segments A and B were linearized with the BsrGI and
PstI enzymes, respectively, and treated as described
previously (25). The linearized DNA was used to produce in
vitro transcripts with the T7 mMessage mMachine kit (Ambion) according
to the manufacturer's instructions. Briefly, approximately 3 µg of
linearized DNA template was added to the transcription reaction mixture
(20 µl) containing 40 mM Tris-HCl (pH 7.9); 10 mM NaCl; 6 mM
MgCl2; 2 mM spermidine; 0.5 mM (each) ATP, CTP, and UTP;
0.1 mM GTP; 0.25 mM cap analog [m7G(5')ppp(5')G]; 120 U of RNasin;
and 150 U of T7 RNA polymerase and incubated at 37°C for 1 h.
Equimolar amounts of RNA transcripts of segments A and B (
8 µg
each) were directly used to transfect cells by the electroporation technique.
Inoculation of CAM. Eleven-day-old embryos were used for the CAM inoculation. Briefly, a hole was punched at the air cell as well as in the side of the egg, where the vein structure is well developed. The air was removed from the air cell with a syringe. The supernatant (100 to 500 µl) was dropped onto the CAM with a syringe through the hole punched in the side of the egg. Both holes were sealed, and the embryo was incubated for 6 days. The embryo was examined daily for survival by candling. Death of the embryo is often a sign of virus infection. After 6 days, the embryo was examined for other signs of viral infection, such as lesions on the CAM, lesions on the embryo, or stunting of the embryo's growth.
Characterization of recovered IBDV. To determine the specificity of the recovered viruses, CEF cells were infected with the transfectant viruses and the infected cells were analyzed by immunofluorescence assay with rabbit anti-IBDV polyclonal serum, as described previously (25). To examine viral structural proteins expressed by recovered chimeric viruses, the viruses (including the one propagated in the CAM) were purified by sucrose gradient centrifugation and analyzed by Western blotting, as described previously (26, 39). To further characterize the recovered virus, RT-PCR was performed on the chimeric virus with the appropriate primer pair, used to produce the original clone. The resulting PCR product was directly sequenced as described above using one of the primers of the primer pair.
Growth curve of chimeric IBDV. To analyze the growth characteristics of IBDV, confluent secondary CEF cells (in T-25 flasks) were infected with one of the recovered virus stocks (generated after five passages in Vero or CEF cells) at a multiplicity of infection of 0.1. Infected cell cultures were harvested at different time intervals, and the titer of infectious progeny was determined by plaque assay on CEF cells as described previously (25). For rIMVP2, which does not propagate in tissue culture, a 50% egg infectious dose (EID50) was used to determine the virus titer. Serial dilutions of the virus were made and then inoculated into CAMs as described previously. For each dilution, the number of embryos dead or showing lesions was determined. Then, and EID50 was determined using the Reed-Muench formula.
Chicken inoculation. Three-week-old specific-pathogen-free chickens were obtained (SPAFAS, Inc.) and housed in isolators. Prior to inoculation, the chickens were bled, and their sera were tested by ELISA to ensure that they were negative for IBDV-specific antibodies. Eight groups of chickens were inoculated by the ocular route with either culture medium or wild-type IM, D78, rIMB, rIMVP43, rIMVP4, GLSVP2, or rIMVP2 virus. For viruses that were able to replicate in cell culture, a dose of 1,000 PFU was administered to each group of chickens, whereas a dose of 1,000 EID50 was given to chickens in the IM and rIMVP2 groups. After 3 days, any surviving chickens were humanely killed and the bursae were excised and bisected. One hemisection was used for RT-PCR assay and AC-ELISA, while the other was fixed and sectioned for histopathological examination.
Identification of recovered viruses by RT-PCR and AC-ELISA. In order to determine whether the nucleotide sequence in the recovered viruses is of chimeric origin, total nucleic acids from IBDV-infected CEF cells, CAMs, or bursal homogenates were isolated and analyzed by RT-PCR, as described above. Segment-specific primers were used for RT of genomic RNA. Following RT, the reaction products were amplified by PCR with the desired segment-specific primer, and the amplified products were either directly sequenced or cloned into the pCR2.1 vector and then sequenced as described above. Generally, the nucleotide sequence in chimeric viruses was determined twice, once after recovery in vitro and again after in vivo studies of bursal homogenates. The recovered viruses were further characterized with a panel of IBDV-specific MAbs in an AC-ELISA, as previously described (40).
Histopathological studies. The bursa tissues were fixed by immersion in 10% neutral buffered formalin. The ratio of fixative to bursa exceeded 10:1. Seven days later, a cross sectional portion of each bursa was processed through paraffin, stained with hematoxylin and eosin, and examined with a light microscope. The severity of the lesion was graded on a scale of 1 to 5, based on the extent of the lymphocyte necrosis, follicular depletion, and atrophy.
Nucleotide sequence accession numbers. The complete nucleotide sequences of IBDV genome segments A and B of the IM strain have been deposited in the GenBank database under accession no. AY029166 and AY029165, respectively.
| |
RESULTS |
|---|
|
|
|---|
Sequence analysis of segments A and B of virulent IBDV strain
IM.
We determined the complete nucleotide sequences of IM IBDV
genome segments A and B, including the 5'- and 3'-terminal sequences. These segments are 3,261 and 2,827 bp long, respectively, which is
identical to the sizes of the segments of strain D78. Comparison of the
5'- and 3'-terminal sequences of both IM segments with those of the D78
strain showed nucleotide substitutions of A
G and T
C at positions
69 and 80 in segment A and G
A and A
G at positions 59 and 69 in
segment B, respectively. Comparison of the deduced amino acid sequences
of IM segments A and B with those of the D78 strain showed 98.82 and
99.32% identity at the amino acid level, respectively. There are a
total of 12 amino acid substitutions in segment A between IM and D78,
of which seven are located in VP2, three in VP4, and two in the VP3
region of the polyprotein (Table 1). Furthermore, there are a total of
seven amino acid changes in segment B between IM and D78, including an
additional amino acid residue at the C terminus of VP1 in the IM strain
(Table 1). This suggests that the classical strain IM is closely
related to the D78 vaccine strain. A phylogenetic analysis, based on
the deduced amino acid sequences of segments A and B of very virulent or virulent strains of IBDV, revealed two distinct groups. The first
group consisted of classical virulent strains, namely, IM, STC, Edgar,
and 52/70, that were isolated in the early 1960s and 1970s and caused
about 30% mortality. The second group comprised all very virulent
strains, such as UK661 (United Kingdom), OKYM (Japan), and HK46 (Hong
Kong), that were isolated in the late 1980s and early 1990s and caused
70% mortality (data not shown).
Construction of full-length and chimeric cDNA clones. To identify the molecular determinants of the virulence, pathogenic phenotype, and cell tropism of IBDV, we constructed chimeric cDNA clones between the attenuated vaccine strain D78 and the virulent strain IM or the variant GLS strain. Figure 1 shows the construction of these clones, in which VP2, VP4, and VP4-VP3 coding sequences of IM or GLS were substituted in the D78 backbone. The chimeric nature of these clones was confirmed by DNA sequence analysis. In addition, we also constructed a full-length cDNA clone of IM segment B to determine whether the RNA polymerase would play a role in virulence or cell tropism. The clones were constructed with a pUC19 vector, and all contained a T7 promoter sequence preceding the 5' noncoding regions of the full-length cDNA clones. The functionality of all these clones was tested by in vitro transcription-coupled translation reactions, which yielded protein products that comigrated with the marker IBDV proteins after fractionation on a sodium dodecyl sulfate-12.5% polyacrylamide gel and autoradiography (data not shown).
Transfection and recovery of chimeric viruses.
To identify the
protein(s) responsible for the cell tropism, virulence, and pathogenic
phenotype of IBDV, we transfected Vero cells by an electroporation
procedure with combined plus-sense transcripts derived from various
plasmids, as shown in Table 2. From six
transfection experiments, we recovered three chimeric viruses (rGLSVP2,
rIMVP4, and rIMVP3) and the parental D78 virus, rD78, containing the
tagged sequences. No other viruses could be recovered in Vero cells,
even after five attempts, when the cRNA transcripts comprised the
coding regions of the IM VP1 (pUC19IMB) or VP2 (pUC19IMVP2) protein.
Therefore, CEF and Vero cells were transfected in parallel with the
transcripts derived from the plasmid pairs (i) pUC19IMB and
pUC19FLAD78mut, (ii) pUC19IMVP2 and pUC19D78B, and (iii) pUC19D78B and
pUC19FLAD78mut. From these transfections (done in duplicate), the rIMB
virus was recovered only in CEF cells, as shown in Table 2, whereas the
parental rD78 virus was recovered in both Vero and CEF cells, as
expected. To determine the presence of infectious virus in transfected
Vero cells, the cells were freeze-thawed twice, and the supernatants were used to infect CEF cells. No virus could be recovered even after
four passages in CEF cells. This result suggests that VP1 contains the
determinants for cell-specific replication in Vero cells. Furthermore,
the rIMVP2 virus (containing the IM VP2 protein) could not be recovered
in CEF cells (after at least five attempts), suggesting that VP2
contains the molecular determinants for cell tropism. Since we could
not recover the rIMVP2 virus, we examined the transient expression of
IBDV-specific proteins in CEF cells. Twenty-four hours
posttransfection, we detected the presence of viral proteins by
immunofluorescence assay, using anti-IBDV polyclonal serum (data not
shown). Therefore, to assess the presence of infectious virus in
transfected CEF cells, the cells were freeze-thawed twice, and the
supernatants were used for CAM inoculation of 11-day-old embryonated
eggs. After 6 days, the embryos showed signs of viral infection, and
the recovered rIMVP2 virus was propagated in the CAMs for further
characterization. These results demonstrate that the rIMVP2 virus is
able to replicate in CEF cells after transfection but cannot be
propagated further in CEF cells. Since parental IM or rIMVP2 viruses
are able to grow only in B lymphoid cells and not in CEF cells, it
suggests that the major determinants of B-lymphocyte cell receptors
reside in VP2.
|
Characterization of chimeric viruses.
To verify whether the
recovered viruses were of recombinant origin, the genomic RNAs were
isolated from these viruses and analyzed by RT-PCR using primer pairs
specific for segment A or B. Sequence analysis of the cloned PCR
product confirmed the expected nucleotide sequences in the VP2, VP4, or
VP3 genes of the various chimeric viruses. However, when the VP1 gene
of the recovered rIMB virus was sequenced, it showed reversion of two
amino acid residues to the parental D78 segment B sequence. The
residues that reverted were Gly
Arg and Lys
Glu at amino acid
positions 115 and 653, respectively (Table 1). This result indicates
that VP1 may play a role in cell-specific replication, as we were
unable to recover this virus in Vero cells but could recover it in CEF cells after substitution of the above-mentioned residues. After four
passages of the rIMB virus in CEF cells, the virus could replicate in
Vero cells.
|
In vivo studies and histopathological examination of the
bursa.
To assess the virulence and pathogenic phenotype of the
recovered viruses, groups of 3-week-old chickens were inoculated with 1,000 PFU of rD78, rIMB, rIMVP4, rIMVP43, or rGLSVP2 virus or with
1,000 EID50 of rIMVP2 or IM virus by the ocular route.
Three days postinoculation, the bursa of each
chicken was excised and analyzed for
pathological lesions. Table 3 and Fig. 3
summarize the results of gross pathology and histopathological
examination of bursae obtained from different groups of chickens.
Chickens inoculated with the rD78, rIMB, rIMVP4, and rIMVP43 viruses
showed no gross bursal lesions but had mild-to-moderate (for rIMVP43) microscopic lesions (Table 3 and Fig. 3B to E, respectively). These
results suggest the amino acid changes in the VP1, VP4, and VP3
proteins (Table 1) do not contribute to the virulence or pathogenic
phenotype of IBDV in our system. However, chickens inoculated with
rGLSVP2, rIMVP2, and the parental IM strain exhibited bursal atrophy
(rGLSVP2) or gross hemorrhagic lesions with 20 to 25% mortality in the
rIMVP2 and IM groups (Table 3). Moreover, the sections derived from
these groups showed lymphocytic necrosis and follicular (B-lymphocyte)
depletions due to extensive accumulation of mononuclear cells,
resulting in the loss of distinction between the cortex and medulla of
the infected bursal section (Fig. 3F to H). In contrast, no gross or
microscopic lesions were observed in chickens that were inoculated with
the control medium (Fig. 3A). These results clearly demonstrate that
the virulence and pathogenic-phenotype markers of the U.S. virulent and
variant IBDV strains reside in VP2.
|
|
Detection of viral antigen from the bursa.
To detect the
presence of virus in the bursae of infected chickens, bursae from each
group were pooled and homogenized in M199 medium, and the filtered
homogenate was analyzed by AC-ELISA using a panel of strain-specific
IBDV MAbs. Table 4 shows the reactivity
patterns of various IBDVs recovered from groups of infected chickens.
It should be noted that MAb 21 recognizes all the virulent strains
tested so far, and it is evident that this epitope was present in
chimeric rIMVP2 virus, which is also virulent. Neutralizing MAb 57 is
specific for the GLS variant, and this epitope was also mapped to the
VP2 protein.
|
Determinants of cell tropism, virulence, and pathogenic phenotype
of IBDV.
To identify putative amino acids involved in cell
tropism, and possibly binding to the cell receptor, we compared the
amino acid sequences of the VP2 protein (variable region) of D78, IM, and other selected IBDV strains (Fig.
4A). Comparison of the D78 sequence
(tissue culture) with the bursa-derived IM, Edgar, and STC sequences
showed only four amino acid differences at positions 253, 279, 284, and
330, which are common to other bursa-derived UK661, HK46, and OKYM
sequences, suggesting the involvement of these residues in cell
tropism. To further narrow down the amino acids involved in cell
tropism, we constructed another clone (pUC19
D78VP2), in which amino
acids at positions 279, 284, and 330 were replaced with the D78
sequence in plasmid pUC19IMVP2 (Table 1). However, transfection of CEF
cells with transcripts derived from clones pUC19
D78VP2 and pUCD78B
did not yield a viable virus, implying that residue Q at position 253 (Q253) is also involved in cell tropism. This result is in agreement
with the results of Mundt, who demonstrated that a Q
H substitution
at position 253 is sufficient to allow tissue culture infectivity of
the E/Del virus (23). Furthermore, comparison of the
bursa-derived GLS sequence of genomic segment A with the tissue
culture-adapted GLS-5 sequence (Fig. 4B) reveals only Q
H and A
T
substitutions at positions 253 and 284, respectively, suggesting the
importance of residues Q253 and A284, but not residue S330, in cell
tropism. Taken together, our results indicate that residues Q253, D279,
and A284 of VP2 are involved in the cell tropism of virulent IBDV
strains.
|
| |
DISCUSSION |
|---|
|
|
|---|
Lack of a reverse-genetics system that can generate virulent IBDV has hampered studies of virulence, cell tropism, and pathogenesis. To overcome this limitation, we modified our transfection procedure and developed an efficient method of transfecting Vero or CEF cells by electroporation, followed by passage in the CAM to recover virus that would not propagate in tissue culture (virulent IBDV). Using this technique, we generated five chimeric viruses, including the virulent rIMVP2, and demonstrated that the virulence, cell tropism, and pathogenic-phenotype markers of IBDV reside in VP2. The fact that we recovered the virulent virus after transfection in CEF cells and propagation in embryonated eggs implies that CEF cells do not possess the receptors for virulent IBDV, which replicates only in B lymphoid cells. In addition, we recovered a chimeric virus containing VP1 of the virulent IM strain in CEF cells but not in Vero cells, suggesting that VP1 contains the determinants for cell-specific replication in Vero cells, which is not receptor mediated.
In recent years, a number of investigators have shown that mutations in the viral genome often lead to changes in the virulence, pathogenesis, and cell tropism of animal viruses (7, 8, 14, 16, 20, 29). For example, a single-amino-acid change in the capsid protein VP1 of coxsackievirus was responsible for the virulence phenotype (7). In swine vesicular disease virus (a picornavirus), the genetic determinants of pathogenicity and plaque phenotype were mapped to a single amino acid residue in VP1 and the 2A proteinase, respectively (14). Similarly, the determinants of virulence and enteric tropism in transmissible gastroenteritis virus were mapped to the spike protein of the virus (29). For rotaviruses of groups A and C, a substitution of two or three amino acid residues in the nonstructural protein gene NSP4 was implicated in reduced virulence (8). In the case of Sindbis virus, the genetic determinants responsible for the pathogenic properties were mapped to the E2 glycoprotein and the 5' noncoding region (16). In our case, the 5' noncoding region of the virulent IM strain does not contain the determinants for virulence, since the rIMVP2 virus, lacking the two nucleotide changes in the 5' noncoding region of wild-type IM, was still virulent and caused hemorrhagic bursal lesions.
To the best of our knowledge, this is the first report demonstrating that the polymerase (VP1) of virulent IBDV carries the determinant for cell-specific viral replication, since we could not recover the virus (rIMB) in Vero cells. However, once we recovered this virus in CEF cells, it could be propagated in Vero cells. Sequence analysis of the VP1 gene of the rIMB virus showed reversion of two amino acid residues at positions 115 and 653 to those of the D78 vaccine strain, which suggests that these residues may be necessary for replication in Vero cell culture (Table 1). This finding is somewhat analogous to the case of lymphocytic choriomeningitis virus, where it was shown that a single-amino-acid substitution in the polymerase gene could enhance viral replication in macrophages (20). Furthermore, our results indicate that the rIMB virus does not induce hemorrhagic lesions in the bursae of infected chickens (Table 3 and Fig. 3C), suggesting that VP1 of the IM strain is not responsible for virulence or the pathogenic phenotype, in agreement with the results of Boot et al. (4). This result is also in accord with that for infectious pancreatic necrosis virus (another birnavirus), where it was shown by generating reassortants between virulent and avirulent strains that the virulence of infectious pancreatic necrosis virus is associated with segment A, which encodes the structural proteins, and not segment B, which encodes VP1 (31).
From earlier studies of IBDV, Yamaguchi and coworkers identified amino acid residues responsible for attenuation of the very virulent OKYM strain by comparing the sequence of the virus, which was obtained after serial passage in non-B lymphoid chicken cells (42). Comparison of the deduced amino acid sequences of the very virulent (OKYM) and attenuated (OKYMT) strains showed specific amino acid substitutions within the hypervariable region of the VP2 protein. Based on these findings, Lim and coworkers mutated residues 279 and 284 of VP2 by site-directed mutagenesis and demonstrated that the very virulent HK46 strain of IBDV could be adapted to CEF cell culture (17). Similarly, Mundt reported that residues 253 and 284 of the VP2 proteins of the variant virus are necessary for tissue culture infectivity (23). However, none of these viruses were tested in chickens to verify the roles of these residues in IBDV virulence and pathogenicity. Our results indicate that VP2 carries the major determinant of cell tropism in IBDV, since we could not recover the rIMVP2 virus in Vero or CEF cells but were able to recover it after passage in the CAM. This was expected, since virulent IBDV does not grow in tissue culture and can only replicate in bursal cells. These results imply that bursal cells possess virus receptors in addition to the one that is present in tissue culture cells which VP2 interacts with. Furthermore, our results clearly demonstrate that VP2 contains the determinants for the virulence and the pathogenic phenotype of IBDV. However, these results are in contrast to those reported by Boot and coworkers, who stated that VP2 is not the sole determinant of the very virulent phenotype due to the fact that their recombinant virus containing VP2 of the very virulent strain did not induce morbidity or mortality (4). In our case, rIMVP2 virus containing the VP2 region of the virulent strain caused hemorrhagic bursal lesions and mortality equivalent to those of the parental IM virus, suggesting that the virulence and pathogenic-phenotype markers of IBDV reside in VP2. This is further supported by the results for chimeric rGLSVP2 virus (containing VP2 of the variant strain), which caused bursal atrophy, a characteristic phenotype of a variant virus (Table 3). Comparison of the GLS-5 sequence with the D78 sequence showed five unique amino acid differences at positions 222, 249, 254, 270, and 330 (Fig. 4B), which are common to other variant GLS, E/Del, and A/Del sequences, suggesting the involvement of these residues in the variant phenotype. In earlier studies, we mapped the classic MAb B69 neutralization epitope (which is absent in the variant viruses) to residues at positions 222, 249, and 254 (38, 41). Therefore, it is apparent that residues T/Q222, K249, and S254 are important in inducing a characteristic phenotype of the variant IBDVs.
In conclusion, we have demonstrated that VP1 carries the determinants for cell-specific replication of IBDV in Vero cells and VP2 carries the determinants for cell tropism. The amino acids involved in binding with the B lymphoid cells are Q253, D279, and A284. Furthermore, the virulence factor of IBDV strain IM resides in VP2 and, based on the reactivity with conformation-dependent MAb 21, residues Q253, D279, and A284 are most likely involved in maintaining this conformation and inducing the pathogenic phenotype (hemorrhagic lesions) of virulent IBDV. However, it is possible that VP4 and VP3 carry additional determinants for virulence, as the rIMVP43 virus also induced slightly more microscopic lesions than the parental D78 virus. In addition, the cooperative effect due to the expression of the 17-kDa NS protein in virulence should not be ruled out, as we have shown that the 17-kDa knockout mutant of strain D78 is nonpathogenic (43). It would be interesting to see whether the NS-deficient mutant of the IM or GLS virus would induce similar pathological lesions and cause immunosuppression.
| |
ACKNOWLEDGMENTS |
|---|
We thank Donald L. Nuss for reviewing the manuscript, and we thank Gerard H. Edwards, Yi Liu, Subbiah Elankumaran, and Ruby Paramadhas for technical assistance.
This work was supported by a grant from the U.S. Department of Agriculture (NRICGP 97-02492) to V.N.V.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Center for Agricultural Biotechnology, 6126 Plant Sciences Building, University of Maryland, College Park, MD 20742. Phone: (301) 405-4777. Fax: (301) 314-9075. E-mail: vakharia{at}umbi.umd.edu.
Present address: Wyeth-Lederle Vaccines and Pediatrics, Marietta,
PA 17547.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Azad, A. A., S. A. Barrett, and K. J. Fahey. 1985. The characterization and molecular cloning of the double-stranded RNA genome of an Australian strain of infectious bursal disease virus. Virology 143:35-44[CrossRef][Medline]. |
| 2. | Becht, H. 1980. Infectious bursal disease virus. Curr. Top. Microbiol. Immunol. 90:107-121[Medline]. |
| 3. | Birghan, C., E. Mundt, and A. E. Gorbalenya. 2000. A non-canonical lon proteinase lacking the ATPase domain employs the Ser-Lys catalytic dyad to exercise broad control over the life cycle of a double-stranded RNA virus. EMBO J. 19:114-123[CrossRef][Medline]. |
| 4. |
Boot, H. J.,
A. A. ter Huurne,
A. J. Hoekman,
B. P. Peeters, and A. L. Gielkens.
2000.
Rescue of very virulent and mosaic infectious bursal disease virus from cloned cDNA: VP2 is not the sole determinant of the very virulent phenotype.
J. Virol.
74:6701-6711 |
| 5. | Böttcher, B., N. A. Kiselev, V. Y. Stel'Mashchuk, N. A. Perevozchikova, A. V. Borisov, and R. A. Crowther. 1997. Three-dimensional structure of infectious bursal disease virus determined by electron cryomicroscopy. J. Virol. 71:325-330[Abstract]. |
| 6. |
Brown, M. D.,
P. Green, and M. A. Skinner.
1994.
VP2 sequences of recent European `very virulent' isolates of infectious bursal disease virus are closely related to each other but are distinct from those of `classical' strains.
J. Gen. Virol.
75:675-680 |
| 7. |
Caggana, M.,
P. Chan, and A. Ramsingh.
1993.
Identification of a single amino acid residue in the capsid protein VP1 of coxsackievirus B4 that determines the virulent phenotype.
J. Virol.
67:4797-4803 |
| 8. | Chang, K. O., Y. J. Kim, and L. J. Saif. 1999. Comparisons of nucleotide and deduced amino acid sequences of NSP4 genes of virulent and attenuated pairs of group A and C rotaviruses. Virus Genes 18:229-233[CrossRef][Medline]. |
| 9. | Dobos, P., L. Berthiaume, J. A. Leong, F. S. Kibenge, H. Müller, and B. L. Nicholoson. 1995. Family Birnaviridae, p. 240-244. In F. A. Murphy, C. M. Fauquet, D. H. L. Bishop, S. A. Ghabrial, A. W. Jarvis, G. P. Martielli, M. O. Mayo, and M. D. Summers (ed.), Virus taxonomy. Springer-Verlag, Vienna, Austria. |
| 10. |
Dobos, P.,
B. J. Hill,
R. Hallett,
D. T. Kells,
H. Becht, and D. Teninges.
1979.
Biophysical and biochemical characterization of five animal viruses with bisegmented double-stranded RNA genomes.
J. Virol.
32:593-605 |
| 11. |
Fahey, K. J.,
K. Erny, and J. Crooks.
1989.
A conformational immunogen on VP-2 of infectious bursal disease virus that induces virus-neutralizing antibodies that passively protect chickens.
J. Gen. Virol.
70:1473-1481 |
| 12. |
Hudson, P. J.,
N. M. McKern,
B. E. Power, and A. A. Azad.
1986.
Genomic structure of the large RNA segment of infectious bursal disease virus.
Nucleic Acids Res.
14:5001-5012 |
| 13. |
Jagadish, M. N.,
V. J. Staton,
P. J. Hudson, and A. A. Azad.
1988.
Birnavirus precursor polyprotein is processed in Escherichia coli by its own virus-encoded polypeptide.
J. Virol.
62:1084-1087 |
| 14. |
Kanno, T.,
D. Mackay,
T. Inoue,
G. Wilsden,
M. Yamakawa,
R. Yamazoe,
S. Yamaguchi,
J. Shirai,
P. Kitching, and Y. Murakami.
1999.
Mapping the genetic determinants of pathogenicity and plaque phenotype in swine vesicular disease virus.
J. Virol.
73:2710-2716 |
| 15. |
Kibenge, F. S.,
A. S. Dhillon, and R. G. Russell.
1988.
Biochemistry and immunology of infectious bursal disease virus.
J. Gen. Virol.
69:1757-1775 |
| 16. |
Kobiler, D.,
C. M. Rice,
C. Brodie,
A. Shahar,
J. Dubuisson,
M. Halevy, and S. Lustig.
1999.
A single nucleotide change in the 5' noncoding region of Sindbis virus confers neurovirulence in rats.
J. Virol.
73:10440-10446 |
| 17. |
Lim, B. L.,
Y. Cao,
T. Yu, and C. W. Mo.
1999.
Adaptation of very virulent infectious bursal disease virus to chicken embryonic fibroblasts by site-directed mutagenesis of residues 279 and 284 of viral coat protein VP2.
J. Virol.
73:2854-2862 |
| 18. | Lin, Z., A. Kato, Y. Otaki, T. Nakamura, E. Sasmaz, and S. Ueda. 1993. Sequence comparisons of a highly virulent infectious bursal disease virus prevalent in Japan. Avian Dis. 37:315-323[CrossRef][Medline]. |
| 19. |
Lombardo, E.,
A. Maraver,
J. R. Castón,
J. Rivera,
A. Fernández-Arías,
A. Serrano,
J. L. Carrascosa, and J. F. Rodriguez.
1999.
VP1, the putative RNA-dependent RNA polymerase of infectious bursal disease virus, forms complexes with the capsid protein VP3, leading to efficient encapsidation into virus-like particles.
J. Virol.
73:6973-6983 |
| 20. |
Matloubian, M.,
S. R. Kolhekar,
T. Somasundaram, and R. Ahmed.
1993.
Molecular determinants of macrophage tropism and viral persistence: importance of single amino acid changes in the polymerase and glycoprotein of lymphocytic choriomeningitis virus.
J. Virol.
67:7340-7349 |
| 21. | McFerran, J. B., M. S. McFerran, E. R. McKillop, T. J. Conner, R. M. McCracken, D. S. Collins, and G. M. Allan. 1980. Isolation and serological studies with infectious bursal disease from fowl, turkeys, and ducks: demonstration of a second serotype. Avian Pathol. 9:384-392. |
| 22. | Mengel-Whereat, S. A. 1995. Development of a monoclonal antibody for the detection of highly virulent classic infectious bursal disease virus. M.S. thesis. University of Maryland, College Park. |
| 23. |
Mundt, E.
1999.
Tissue culture infectivity of different strains of infectious bursal disease virus is determined by distinct amino acids in VP2.
J. Gen. Virol.
80:2067-2076 |
| 24. |
Mundt, E.,
J. Beyer, and H. Müller.
1995.
Identification of a novel viral protein in infectious bursal disease virus-infected cells.
J. Gen. Virol.
76:437-443 |
| 25. |
Mundt, E., and V. N. Vakharia.
1996.
Synthetic transcripts of double-stranded Birnavirus genome are infectious.
Proc. Natl. Acad. Sci. USA
93:11131-11136 |
| 26. |
Nick, H.,
D. Cursiefen, and H. Becht.
1976.
Structural and growth characteristics of infectious bursal disease virus.
J. Virol.
18:227-234 |
| 27. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. |
| 28. | Sanchez, A. B., and J. F. Rodriguez. 1999. Proteolytic processing in infectious bursal disease virus: identification of the polyprotein cleavage sites by site-directed mutagenesis. Virology 262:190-199[CrossRef][Medline]. |
| 29. |
Sanchez, C. M.,
A. Izeta,
J. M. Sanchez-Morgado,
S. Alonso,
I. Sola,
M. Balasch,
J. Plana-Duran, and L. Enjuanes.
1999.
Targeted recombination demonstrates that the spike gene of transmissible gastroenteritis coronavirus is a determinant of its enteric tropism and virulence.
J. Virol.
73:7607-7618 |
| 30. |
Sanger, F.,
S. Nicklen, and A. R. Coulson.
1977.
DNA sequencing with chain terminating inhibitor.
Proc. Natl. Acad. Sci. USA
74:5463-5467 |
| 31. | Sano, M., N. Okamoto, H. Fukuda, M. Saneyoshi, and T. Sano. 1992. Virulence of infectious pancreatic necrosis virus is associated with the larger RNA segment (RNA segment A). J. Fish Dis. 15:283-293[CrossRef]. |
| 32. | Snyder, D. B., D. P. Lana, P. K. Savage, F. S. Yancey, S. A. Mengel, and W. W. Marquardt. 1988. Differentiation of infectious bursal disease viruses directly from infected tissues with neutralizing monoclonal antibodies: evidence of a major antigenic shift in recent field isolates. Avian Dis. 32:535-539[CrossRef][Medline]. |
| 33. | Snyder, D. B., V. N. Vakharia, and P. K. Savage. 1992. Naturally occurring neutralizing monoclonal antibody escape variants define the epidemiology of infectious bursal disease viruses in the United States. Arch. Virol. 127:89-101[CrossRef][Medline]. |
| 34. |
Spies, U., and H. Müller.
1990.
Demonstration of enzyme activities required for cap structure formation in infectious bursal disease virus, a member of the birnavirus group.
J. Gen. Virol.
71:977-981 |
| 35. |
Spies, U.,
H. Müller, and H. Becht.
1989.
Nucleotide sequence of infectious bursal disease virus genome segment A delineates two major open reading frames.
Nucleic Acids Res.
17:7982 |
| 36. | Spies, U., H. Müller, and H. Becht. 1987. Properties of RNA polymerase activity associated with infectious bursal disease virus and characterization of its reaction products. Virus Res. 8:127-140[CrossRef][Medline]. |
| 37. | Tsukamoto, K., T. Matsumura, M. Mase, and K. Imai. 1995. A highly sensitive, broad-spectrum infectivity assay for infectious bursal disease virus. Avian Dis. 39:575-586[CrossRef][Medline]. |
| 38. | Vakharia, V. N. 1997. Development of recombinant vaccines against infectious bursal disease. Biotechnol. Annu. Rev. 3:151-168. |
| 39. |
Vakharia, V. N.,
D. B. Snyder,
J. He,
G. H. Edwards,
P. K. Savage, and S. A. Mengel-Whereat.
1993.
Infectious bursal disease virus structural proteins expressed in a baculovirus recombinant confer protection in chickens.
J. Gen. Virol.
74:1201-1206 |
| 40. | Vakharia, V. N., J. He, B. Ahamed, and D. B. Snyder. 1994. Molecular basis of antigenic variation in infectious bursal disease virus strains. Virus Res. 31:265-273[CrossRef][Medline]. |
| 41. | Vakharia, V. N., D. B. Snyder, and S. A. Mengel-Whereat. December 2000. Chimeric infectious bursal disease virus cDNA clones, expression products and vaccines based thereon. U.S. patent 6,156,314. |
| 42. | Yamaguchi, T., M. Ogawa, Y. Inoshima, M. Miyoshi, H. Fukushi, and K. Hirai. 1996. Identification of sequence changes responsible for the attenuation of highly virulent infectious bursal disease virus. Virology 223:219-223[CrossRef][Medline]. |
| 43. |
Yao, K.,
M. A. Goodwin, and V. N. Vakharia.
1998.
Generation of a mutant infectious bursal disease virus that does not cause bursal lesions.
J. Virol.
72:2647-2654 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||